Pharma & Bio
Lifestyle
Will Investor Sentiment Return Amid the Semiconductor Market Correction? KMPHARMACEUTICAL Co.,Ltd. and LEMON COMPANY LIMITED Hit Daily Price Limits [Bio Market Watch]
As the domestic securities market has recently entered a period of consolidation for semiconductor and key information technology (IT) stocks, investor sentiment is rapidly shifting back toward the ph…
Lifestyle
Will Investment Sentiment Return to the Biotech Sector Amid a Tech Correction? KM Pharmaceutical and Lemon Healthcare Hit the Daily Price Limit [K-Bio Pulse]
As the domestic stock market has recently entered a lull centered on semiconductors and key Information Technology (IT) stocks, investment sentiment is rapidly shifting back to the pharmaceutical and …
Technology
SAMSUNG BIOLOGICS Sees Strong Momentum in the Second Half... How Much Will It Rebound?
SAMSUNG BIOLOGICS(207940)expressed confidence that its order intake, which remained at around $400 million in the first half of this year, will rebound significantly in the second half. This is not me…
Technology
Inverse ETFs Dominate the Bear Market [K-Bio Pulse]
On July 29, South Korea’s domestic stock market continued to weaken, causing inverse exchange-traded funds (ETFs) tracking the KOSDAQ’s decline to dominate the list of top gainers. More than half of t…
Technology
[Bio Spotlight] A Bear Market Where Only Inverse Funds Thrived… T&R Biofab Co., Ltd. and Lemon Healthcare Held Steady Thanks to Earnings and Technology
On the 29th, as the domestic stock market once again failed to escape a downtrend, inverse exchange-traded funds (ETFs) betting on a decline in the KOSDAQ index swept the top ranks in terms of returns…
Business·Industry
L&K BIOMED CO., LTD.: “Amended Global Distribution Agreement for Spinal Implants… Simultaneously in Discussions with Other Global Companies”
“There have been changes to the distribution agreement with a global company that we have been pursuing. While discussions regarding a distribution agreement in the U.S. have been suspended due to a s…
Lifestyle
"From Anchors to Surgical Instruments"... OSTEONIC Co., Ltd. Sees Another Jump in Earnings This Year Thanks to Its Package Strategy
OSTEONIC Co., Ltd.(226400)is set to achieve a quantum leap in performance through a “package strategy” that combines surgical instruments with its SportsMedicine implants. With the “Suture Passer”—a s…
Lifestyle
Cellbion Co., Ltd Begins Clinical Trial Combining Keytruda with Merck... Company Valuation Set to Rise
#Cellbion Co., Ltd, a company specializing in radiopharmaceuticals (RPT), is expected to see its corporate value reassessed as it moves to commercialize a prostate cancer treatment and enhance the val…
Lifestyle
Investors Ask... What Is the Post-IPO Growth Roadmap and What Are the Risk Factors? [In-Depth Look at Ingenia ③]
Ingenia Therapeutics is set to receive milestone payments totaling 50 billion won from Merck by the end of this year. In addition, Edaily’s premium pharma and biotech content platform, PharmEdaily, ha…
Lifestyle
The Key Technology Merck Has Set Its Sights On... Targeting a $5 Billion Market Value [In-Depth Look at Ingenia, Part 2]
The driving force behind global pharmaceutical and biotech companies’ large-scale investment in Ingenia Therapeutics’ technology lies in “LCIDEC” (Ligand Capture, Internalization, Degradation in EC), …